Abstract |
One hundred ninety-five patients suffering from active rheumatoid arthritis were included in a two-week double blind multicentric study, whose purpose was to compare the efficacy and tolerance of a daily dose of 600 mg of pirprofen to that of 1200 mg and the placebo. The results show that there is a dose-effect relationship of definite clinical interest. Thus, the investigators judged the clinical results satisfactory in 60% of the patients in the 1200 mg group (400 mg t.i.d.) 44% of those in the 600 mg group and 36% of those on placebo. The difference is statistically significant (p less than 0.05). Side effects, primarily digestive, were noted in 34% of patients receiving 1200 mg/day, 15% of 600 mg/day and 32% placebo. 2 patients in the 1200 mg group interrupted their treatment for gastralgia and 1 patient on placebo for palpitations.
|
Authors | J P Camus, A Prier |
Journal | La Nouvelle presse medicale
(Nouv Presse Med)
Vol. 11
Issue 33
Pg. 2481-3
(Aug 28 1982)
ISSN: 0301-1518 [Print] France |
Vernacular Title | Traitement de la polyarthrite rhumatoïde par pirprofène. Comparaison de deux posologies. |
PMID | 7133972
(Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Inflammatory Agents
- Phenylpropionates
- pirprofen
|
Topics |
- Adolescent
- Adult
- Aged
- Anti-Inflammatory Agents
(administration & dosage, adverse effects)
- Arthritis, Rheumatoid
(drug therapy)
- Double-Blind Method
- Drug Evaluation
- Female
- Humans
- Male
- Middle Aged
- Phenylpropionates
(administration & dosage, adverse effects)
|